Paulo Ricardo Criado

ORCID: 0000-0001-9785-6099
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Urticaria and Related Conditions
  • Autoimmune Bullous Skin Diseases
  • Nail Diseases and Treatments
  • Fungal Infections and Studies
  • Dermatology and Skin Diseases
  • Drug-Induced Adverse Reactions
  • Systemic Lupus Erythematosus Research
  • Cutaneous lymphoproliferative disorders research
  • Mast cells and histamine
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Venous Thromboembolism Diagnosis and Management
  • Vasculitis and related conditions
  • Dermatological diseases and infestations
  • Dermatological and COVID-19 studies
  • Autoimmune and Inflammatory Disorders
  • Contact Dermatitis and Allergies
  • Antifungal resistance and susceptibility
  • Eosinophilic Disorders and Syndromes
  • Blood Coagulation and Thrombosis Mechanisms
  • Infectious Diseases and Mycology
  • Genetic and rare skin diseases.
  • Skin Diseases and Diabetes
  • Oral Health Pathology and Treatment
  • Plant Pathogens and Fungal Diseases
  • Allergic Rhinitis and Sensitization

Faculdade de Medicina do ABC
2006-2025

Centro Universitário Lusíada
2023-2025

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2013-2023

Pontifícia Universidade Católica do Paraná
2023

Fundação do ABC
2019-2022

Universidade de São Paulo
2011-2021

Alergo Dermatologia Integrada
2020-2021

Sociedade Brasileira de Cardiologia
2021

Universidade Brasil
2007-2020

Universidade Federal do ABC
2020

This update and revision of the international guideline for urticaria was developed following methods recommended by Cochrane Grading Recommendations Assessment, Development Evaluation (GRADE) working group. It is a joint initiative Dermatology Section European Academy Allergology Clinical Immunology (EAACI), Global Allergy Asthma Network (GA²LEN) its Urticaria Angioedema Centers Reference Excellence (UCAREs ACAREs), Forum (EDF; EuroGuiDerm), Asia Pacific Association Allergy, with...

10.1111/all.15090 article EN Allergy 2021-09-18
Emek Kocatürk Andaç Salman Iván Chérrez-Ojeda Paulo Ricardo Criado Jonny Peter and 93 more Elif Cömert-Özer Mohamed Abuzakouk Rosana Câmara Agondi Mona Al‐Ahmad Sabine Altrichter Rand Arnaout L. Karla Arruda Riccardo Asero Andrea Bauer Moshe Ben‐Shoshan Jonathan A. Bernstein Mojca Bizjak Isabelle Boccon‐Gibod Hanna Bonnekoh Laurence Bouillet Zenon Brzoza Paula Busse Régis A. Campos Emily Carne Niall Conlon Roberta Fachini Jardim Criado Eduardo Magalhães de Souza Lima Semra Demir Joachim Dissemond Sibel Doğan Irina V. Dorofeeva Luís Felipe Ensina Ragıp Ertaş Silvia Ferrucci Ignasi Figueras‐Nart Daria Fomina Sylvie M. Franken Atsushi Fukunaga Ana M. Giménez‐Arnau Kiran Godse Margarida Gonçalo Maia Gotua Clive Grattan Carole Guillet Naoko Inomata Thilo Jakob Gül Karakaya Alicja Kasperska−Zając Constance H. Katelaris Mitja Košnik Dorota Krasowska Kanokvalai Kulthanan Muthu Sendhil Kumaran Claudia Lang José Ignacio Larco‐Sousa Elisavet Lazaridou Tabi A. Leslie Undine Lippert Oscar Calderón Llosa Michaël Makris Alexander Marsland Iris Medina Raisa Meshkova Esther Bastos Palitot Claudio Alberto Salvador Parisi Julia Pickert German D. Ramón Mónica Rodríguez-González Nelson Augusto Rosário Filho Michael Rudenko Krzysztof Rutkowski Jorge Sánchez Sibylle Schliemann Bülent Enis Şekerel Faradiba Sarquis Serpa E. Serra‐Baldrich Zhiqiang Song A. Soria Maria Staevska Petra Staubach Anna Tagka Shunsuke Takahagi Simon Francis Thomsen Regina Treudler Zahava Vadasz Solange Oliveira Rodrigues Valle Martijn B. A. van Doorn Christian Vestergaard Nicola Wagner Dahu Wang Liangchun Wang Bettina Wedi Paraskevi Xepapadaki Esra Yücel Anna Zalewska‐Janowska Zuotao Zhao Torsten Zuberbier Marcus Maurer

The COVID-19 pandemic dramatically disrupts health care around the globe. impact of on chronic urticaria (CU) and its management are largely unknown.To understand how CU patients affected by pandemic; specialists alter patient management; course in with COVID-19.Our cross-sectional, international, questionnaire-based, multicenter UCARE COVID-CU study assessed consultations, remote treatment, changes medications, clinical consequences.The severely impairs care, less than 50% weekly numbers...

10.1111/all.14687 article EN cc-by-nc Allergy 2020-12-07

This multicenter study aimed to explore whether baseline total immunoglobulin E (IgE) levels could predict omalizumab response in chronic spontaneous urticaria (CSU) patients. Refractory CSU patients, treated with after failing second-generation H1-antihistamines, were analyzed retrospectively across seven centers Brazil. The assessed IgE at baseline, comparing responders non-responders and considering complete partial responses. results showed a significant reduction symptoms...

10.3389/falgy.2024.1451296 article EN cc-by Frontiers in Allergy 2025-01-23

Chromoblastomycosis is a subcutaneous mycosis that remains therapeutic challenge, with no standard treatment and high rates of relapse. On the basis our recent discoveries in mouse models, we tested efficacy topical applications imiquimod to treat patients afflicted this chronic fungal infection. We report results for first 4 recipients imiquimod, all whom displayed marked improvement their lesions, both without concurrent oral antifungal therapy.

10.1093/cid/ciu168 article EN cc-by Clinical Infectious Diseases 2014-03-14

Drug reaction with eosinophilia and systemic symptoms (DRESS) [also called drug-induced hypersensitivity syndrome (DIHS)] includes severe reactions to drugs that need be promptly recognized by physicians.To explore heterogeneity in the clinical presentation of DRESS/DIHS at a large academic hospital Latin America, using criteria defined European Registry Severe Cutaneous Adverse Reactions (RegiSCAR) scoring system.A retrospective medical record review 60 patients diagnostic suspicion...

10.1111/ced.12682 article EN Clinical and Experimental Dermatology 2015-08-14
Marcus Maurer Werner Aberer Rosana Câmara Agondi Mona Al‐Ahmad Maryam Al‐Nesf and 95 more Ignacio J. Ansotegui Rand Arnaout L. Karla Arruda Riccardo Asero Emel Aygören‐Pürsün Aleena Banerji Andrea Bauer Moshe Ben‐Shoshan Alejandro Berardi Jonathan A. Bernstein Stephen Betschel Carsten Bindslev‐Jensen Mojca Bizjak Isabelle Boccon‐Gibod Konrad Bork Laurence Bouillet Henrik Balle Boysen Nicholas Brodszki Sigurd Broesby‐Olsen Paula Busse Thomas Buttgereit Anette Bygum Teresa Caballero Régis A. Campos Mauro Cancian Iván Chérrez-Ojeda Danny M. Cohn Célia Costa Timothy Craig Paulo Ricardo Criado Roberta Fachini Jardim Criado Dorottya Csuka Joachim Dissemond A. Du‐Thanh Luís Felipe Ensina Ragıp Ertaş J E Fabiani Claudio Fantini Henriette Farkas Silvia Ferrucci Ignasi Figueras‐Nart Natalia Lorena Fili Daria Fomina Atsushi Fukunaga Aslı Gelincik Ana M. Giménez‐Arnau Kiran Godse Mark Gompels Margarida Gonçalo Maia Gotua Richard Gower Anete Sevciovic Grumach Guillermo Guidos Fogelbach Michihiro Hide Natalia Ilina Naoko Inomata Thilo Jakob Darío Josviack Hye–Ryun Kang Allen P. Kaplan Alicja Kasperska−Zając Constance H. Katelaris Aharon Kessel Andreas Kleinheinz Emek Kocatürk Mitja Košnik Dorota Krasowska Kanokvalai Kulthanan Muthu Sendhil Kumaran José Ignacio Larco Sousa Hilary Longhurst William R. Lumry Andrew J. MacGinnitie Markus Magerl Michaël Makris Alejandro Malbrán Alexander Marsland Inmaculada Martinez‐Saguer Iris Medina Raisa Meshkova Martin Metz Iman Nasr Jan P. Nicolay Chikako Nishigori Isao Ohsawa Kemal Özyurt Nikolaos G. Papadopoulos Claudio Alberto Salvador Parisi Jonny Peter Wolfgang Pfützner Todor A. Popov Nieves Prior German D. Ramón Adam Reich Avner Reshef

GA2LEN, the Global Allergy and Asthma European Network, HAE international (HAEi), global umbrella organization for world's hereditary angioedema (HAE) patient groups, have launched their joint ACARE (Angioedema Center of Reference Excellence) program, within GA2LEN's center reference excellence (CORE) initiative. Angioedema is a common, heterogeneous, often debilitating chronic condition frequently challenge physicians affected patients, especially patients suffering from recurrent attacks....

10.1111/all.14293 article EN cc-by-nc Allergy 2020-04-05

A plethora of prolonged COVID-19 symptoms, or late manifestations has been reported after acute disease and labeled "post-COVID". The aim this study was to identify the prevalence risk factors for post-COVID up 12 weeks onset COVID-19. An electronic survey conducted evaluate post-COVID-19 severity, demographics, pre-existing diseases. participants were recruited through 88,648 SMS messages, post on social media. associations between variables explored multivariate models. From 6,958...

10.1590/0001-3765202320220143 article EN PubMed 2023-01-01

Abstract Background Livedoid vasculopathy (LV) is a chronic idiopathic disease characterized by painful purpuric macules on lower extremities. Its exact aetiology remains uncertain, but thrombotic and microcirculatory phenomena have been implicated as possible pathogenic factors. Objectives To assess prospectively the frequency of thrombophilia to verify effectiveness anticoagulant therapy among LV patients. Methods Thirty‐four patients were tested for prothrombin time, activated partial...

10.1111/j.1468-3083.2010.03646.x article EN Journal of the European Academy of Dermatology and Venereology 2010-03-24

Dermatological disorders are common in medical practice. In school, however, the time devoted to teaching dermatology is usually very limited. Therefore, online educational systems have increasingly been used education settings enhance exposure dermatology. The present study was designed develop an e-learning program for students and evaluate impact of this on learning. This prospective included second year at University Technology Science, Salvador, Brazil. All attended discussion seminars...

10.1590/s1807-59322011000400016 article EN cc-by-nc Clinics 2011-01-01

Dermatophytes are agents of typically benign superficial infections. However, an increasing number severe infections in immunocompromised hosts has been reported. We aimed to understand the factors underlying existence a cohort patients presenting with chronic widespread dermatophytosis (CWD) due Trichophyton rubrum, but no signs immunodeficiency. Their disease is usually recurrent and difficult manage. Fourteen meeting following criteria for CWD were studied: T. rubrum culture-proven skin...

10.3389/fmicb.2015.00801 article EN cc-by Frontiers in Microbiology 2015-08-04
Coming Soon ...